By the Institute for Health and Socio-Economic Policy
“Throughout the series of briefs we have seen how pharmaceutical companies charge high drug prices1 , enabling these companies to realize enormous profits.2 Through patents3 as well mergers and acquisitions4 they have created a market structure that allows them to charge these high prices.”…
[Click HERE to read the full article]Share